Sittner & Nelson’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$243K Hold
1,149
0.09% 149
2025
Q4
$260K Sell
1,149
-1
-0.1% -$188 0.09% 141
2025
Q3
$181K Hold
1,150
0.07% 156
2025
Q2
$193K Hold
1,150
0.08% 148
2025
Q1
$158K Hold
1,150
0.07% 155
2024
Q4
$136K Hold
1,150
0.06% 150
2024
Q3
$127K Hold
1,150
0.06% 156
2024
Q2
$113K Hold
1,150
0.06% 150
2024
Q1
$129K Hold
1,150
0.06% 143
2023
Q4
$116K Hold
1,150
0.06% 145
2023
Q3
$99.8K Hold
1,150
0.06% 151
2023
Q2
$109K Hold
1,150
0.06% 151
2023
Q1
$86.8K Sell
1,150
-1,250
-52% -$94.3K 0.05% 170
2022
Q4
$185K Buy
2,400
+8
+0.3% +$608 0.11% 117
2022
Q3
$160K Buy
2,392
+2
+0.1% +$127 0.11% 118
2022
Q2
$125K Hold
2,390
0.08% 128
2022
Q1
$136K Buy
2,390
+1,557
+187% +$83.4K 0.08% 123
2021
Q4
$43K Hold
833
0.03% 218
2021
Q3
$41K Buy
833
+750
+904% +$40.7K 0.03% 210
2021
Q2
$5K Hold
83
﹤0.01% 333
2021
Q1
$5K Hold
83
﹤0.01% 333
2020
Q4
$4K Buy
+83
New +$4.31K ﹤0.01% 327

Other funds holding CAH

Sittner & Nelson's CAH Position: Q1 2026 in Review

Sittner & Nelson held its Cardinal Health (CAH) position steady in Q1 2026 at 1,149 shares worth $243K. The position accounts for 0.09% of the portfolio, ranked #149.

Sittner & Nelson first reported a position in CAH in Q4 2020 and has held it in 22 quarters since. The position peaked at $260K in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Sittner & Nelson held 1,149 shares of Cardinal Health worth $243K as of Q1 2026.
  • Sittner & Nelson left its Cardinal Health share count unchanged in Q1 2026.
  • Cardinal Health made up 0.09% of Sittner & Nelson's portfolio in Q1 2026, its #149 holding.
  • Sittner & Nelson first reported a position in Cardinal Health in Q4 2020 and has held it in 22 quarters since.
  • Sittner & Nelson's Cardinal Health position peaked at $260K in Q4 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Sittner & Nelson's 13F filing for Q1 2026, filed 12 May 2026.